China NT Pharma Group Company Limited

Exchange Code Listed Last trade Delisted
HK Main 01011  2011-04-20    
Stock code:
From
to

CCASS holding changes from 2021-09-09 to 2021-09-10

Hit the "stake change" to see the holder's history.

Some data are hidden to fit your display. Rotate?

Row CCASS ID Name Holding Change Stake
%
Stake
Δ %
Last
holding
1 B01130 BOCI SECURITIES LTD 52,607,000 338,500 2.76 0.02 2021-09-10
2 B01417 CHEE TAK SECURITIES LTD 478,500 152,000 0.03 0.01 2021-09-10
3 B01284 HANG SENG SECURITIES LTD 34,521,500 140,000 1.81 0.01 2021-09-10
4 B01695 DAH SING SECURITIES LTD 8,745,500 116,000 0.46 0.01 2021-09-10
5 B01668 BRIGHT SMART SECURITIES INTERNATIONAL 13,121,000 60,000 0.69 0.00 2021-09-10
6 C00033 BANK OF CHINA (HONG KONG) LTD 96,430,425 10,000 5.06 0.00 2021-09-10
7 B01224 MERRILL LYNCH FAR EAST LTD 2,688,438 9,500 0.14 0.00 2021-09-10
8 C00100 JPMORGAN CHASE BANK, NATIONAL 282,173,000 1,500 14.82 0.00 2021-09-10
9 B01345 PHILLIP SECURITIES (HONG KONG) LTD 3,860,000 1,000 0.20 0.00 2021-09-10
10 C00010 CITIBANK N.A. 12,683,039 -2,500 0.67 -0.00 2021-09-10
11 C00093 BNP PARIBAS 1,094,500 -16,000 0.06 -0.00 2021-09-10
12 B01727 ICBC (ASIA) SECURITIES LTD 27,108,000 -50,000 1.42 -0.00 2021-09-10
13 B02102 ZINVEST GLOBAL LTD 32,000 -60,000 0.00 -0.00 2021-09-10
14 B02028 SORRENTO SECURITIES LTD 800,000 -100,000 0.04 -0.01 2021-09-10
15 B01470 HUNG SING SECURITIES LTD 2,499,500 -600,000 0.13 -0.03 2021-09-10
15 Total changed named holdings 538,842,402 0 28.29 0.00
226 Unchanged named holdings 1,362,579,140 0 71.54 0.00
241 Total named holdings 1,901,421,542 0 99.83 0.00
20 Unnamed Investor Participants 2,680,000 0 0.14 0.00
261 Total securities in CCASS 1,904,101,542 0 99.97 0.00
Securities not in CCASS 533,930 0 0.03 0.00
Issued securities 1,904,635,472 0 100.00 0.00 2021-08-31

Trades that settled in this date range

These data are not adjusted for splits or bonus issues during the period.

Trading date2021-09-08
Volume1,268,500
Turnover115,966
Average price0.091

Sign up for our free newsletter

Recommend Renavon to a friend

Copyright & disclaimer, Privacy policy

Back to top